Aligning pharma messaging with real voices

Tern plc

In pharma marketing, message alignment too often remains an art backed by intuition. But the stakes are rising: every pound spent on a campaign that fails to land is a lost opportunity, and worse, a weakening of trust. Talking Medicines’ DrugVoice offers a route into converting raw conversation into real-time intelligence that keeps brand voice in concert with evolving reality. It does this by systematically mapping what healthcare professionals and patients say in natural dialogue, publicly and privately, and then contrasting that narrative with the brand’s intended language.

The core of the solution is an iterative “intelligence flywheel.” First, discovery surfaces signals buried in feedback, social media, clinical forums, or comment threads. Then comes alignment: benchmarks and KPIs are established to quantify where the brand message diverges from reality. After that, measurement tracks shifts in how audiences respond to refined messaging. Finally, evidence analysis explains why certain nuances resonate or miss, enabling adjustments not just in wording but in strategic positioning.

A central pillar is the proprietary “resonance score”, a metric that operationalises how well brand messaging connects with HCPs and patients. It quantifies which messages hit home, where dissonance exists, and how a campaign performs from prelaunch to postlaunch.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines uses AI to turn medical congress discussions into pharma insights

Talking Medicines uses AI to analyse healthcare professional conversations at medical congresses, turning discussions into structured insights that help...

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

Device Authority warns supermarket freezer cyberattack exposes connected device security risks

Device Authority warns that a cyberattack affecting around 700 French supermarkets exposes security weaknesses in connected industrial equipment and...

Breast cancer research highlights importance of patient intelligence in pharma

Talking Medicines highlights how AI-powered patient intelligence can help pharmaceutical companies understand breast cancer treatment experiences and identify unmet...

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Search